Contracture Clinical Trial
— SPORTEUSOfficial title:
Effect of a Protein-enriched Drink on Muscle Function Recovery Following an Acute High Intensity Exercise Bout
There is no conclusive evidence about the effect of intake of protein-enriched drink after and acute high intensity exercise bout on muscle function and damage. The investigators aimed to study the effect of a protein-enriched drink on muscle function recovery following an acute high intensity exercise bout. The present counterbalanced, crossover, and double blind study will involve a total of 12 active men.
| Status | Recruiting |
| Enrollment | 12 |
| Est. completion date | December 2015 |
| Est. primary completion date | December 2015 |
| Accepts healthy volunteers | Accepts Healthy Volunteers |
| Gender | Male |
| Age group | 18 Years to 40 Years |
| Eligibility |
Inclusion Criteria: - Recreational triathletes with 2 years of experience - Maximum oxygen uptake : =55 ml/kg/min - Fat mass: 8-20% measured by dual energy x-ray absorptiometry - Not participating in another study - Not having ergogenic aids - Not participating in a weight loss program - Normal electrocardiogram - Participants must be capable and willing to provide consent, understand exclusion criteria and accept the randomized group assignment Exclusion Criteria: - History of cardiovascular disease - Diabetes or hypertension - Medication for hypertension, hyperlipidemia, hyperuricemia or other illness. - Smoking - Other significant medical conditions that are life-threatening or that can interfere with or be aggravated by exercise. - Unwillingness to either complete the study requirements or to be randomized into control or training group. |
Allocation: Randomized, Intervention Model: Crossover Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Prevention
| Country | Name | City | State |
|---|---|---|---|
| Spain | Biosearch Life | Granada |
| Lead Sponsor | Collaborator |
|---|---|
| Puleva Biotech | Universidad de Granada |
Spain,
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Primary | Isometric muscle strength | Isometric muscle strength of lower limbs at 90% angle. | Change from pre- protein-enriched drink to 24, 48 and 72 hrs post- protein-enriched drink | No |
| Secondary | Muscle soreness of lower limbs self-reported by a visual anagogic scale and with an algometer score. | Muscle soreness of the lower limbs will be self-reported by a visual anagogic scale and with an algometer score. | Change from post- protein-enriched drink to 24, 48 and 72 hrs post- protein-enriched drink | Yes |
| Secondary | Power output assessed with the 30sec. Wingate anaerobic test | Power output will be assessed with the 30sec. Wingate anaerobic test. | Change from post- protein-enriched drink to 24, 48 and 72 hrs post- protein-enriched drink | No |
| Secondary | Creatine kinase | Creatine kinase will be assessed after the protein-enriched drink to assess muscle recovery after a high intensity exercise bout | Change from post- protein-enriched drink to 24, 48 hrs post- protein-enriched drink | No |
| Secondary | Urine Creatinine | Concentration of creatinine in urine will be assessed after the protein-enriched drink to assess muscle recovery after a high intensity exercise bout | Change from post- protein-enriched drink to 24, 48 hrs post- protein-enriched drink | No |
| Secondary | Resting metabolic rate | Change from pre- protein-enriched drink to 24, 48 and 72 hrs post- protein-enriched drink | No | |
| Secondary | Time limit (time that the participant is able to run 90% of his determined maximum aerobic velocity) | We will measure the time that the participant is able to run 90% of his determined maximum aerobic velocity | 24hrs after protein-enriched drink | No |
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT06042907 -
Development, Validation, and Evaluation of a Risk Assessment Tool for Contractures: the ORACLE Study
|
||
| Not yet recruiting |
NCT06377085 -
Repurposing 5-Azacytidine for the Treatment of Muscle Contractures in Children With Cerebral Palsy
|
Phase 1 | |
| Recruiting |
NCT06308380 -
Effectiveness of Rehabilitation Protocol in Patients With Shortened Posterior Leg Muscles
|
N/A | |
| Completed |
NCT01639651 -
The Acute Effect of a Mobilization With Movement Technique to Improve Internal Rotation of the Shoulder
|
Phase 0 | |
| Completed |
NCT01777386 -
Perforator Artery Changes During Suprafascial Pre-expansion of the Perforator Flaps
|
N/A | |
| Recruiting |
NCT06051656 -
Effect of Cryoneurolysis on Pain in Patients With Hand Contracture.
|
||
| Completed |
NCT03008486 -
Long Term Effects of Soft Splints on Stroke Patients and Patients With Disorders of Consciousness
|
Phase 2 | |
| Completed |
NCT01882556 -
Early Use of Botulinum Toxin in Spasticity Post Stroke.
|
Phase 2 | |
| Recruiting |
NCT05440240 -
Percutaneous Needle Fasciotomy +/- Corticosteroid Injection for Dupuytren's Contracture
|
Phase 4 | |
| Recruiting |
NCT03475654 -
A Prospective Trial of Virtual Home Rehabilitation After Burn Injury
|
N/A | |
| Completed |
NCT02975531 -
Simulator of Pompage Technique for Physiotherapists
|
N/A | |
| Completed |
NCT02861521 -
Reducing Recurrent Knee Flexion Contracture by Correcting Leg Length Discrepancy After Total Knee Arthroplasty for OA
|
N/A |